TrialSignal
Clinical trial intelligence report
Pharmacokinetic and Pharmacodynamic Study of Oral Quercetin and Isoquercetin in Healthy Adults and Patients With Hypercoagulable States.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01722669
Status
COMPLETED
Phase
Early Phase 1
Sponsor
Beth Israel Deaconess Medical Center
Executive brief
Investment-Ready Snapshot
This study evaluated the absorption and activity of quercetin and isoquercetin in healthy adults and patients with hypercoagulable states. The trial was conducted by Beth Israel Deaconess Medical Center and involved 38 participants across various arms, assessing pharmacokinetic parameters and pharmacodynamic effects.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01722669
Indication
Healthy
Modality
small molecule
Target
Quercetin and Isoquercetin pharmacokinetics and pharmacodynamics
Intervention
isoquercetin or quercetin
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.